Revance Therapeutics, Inc. 401(k) P/S Plan

Reviewed by PlainRetire Editorial, Retirement Plans Editorial Team

ERISA Form 5500 plan record drawn from DOL EBSA — verify with linked source filings below.

Sponsored by Revance Therapeutics, Inc. · Tennessee · Professional & Technical Services

What the 2023 filing shows

Revance Therapeutics, Inc. 401(k) P/S Plan holds $41M for 493 participants — about $82,994 per participant, down 5.6% over the 2022 plan year.

$41M
total plan assets (2022 EOY): 493
covered participants: $82,994
avg assets per participant: -5.6%
assets change YoY

The plan reported a net loss of $2M for the year — a single-year figure driven by markets and benefit payments, not a measure of plan health.

Total Assets (2023)

$41M

Participants

493

State

Tennessee

Industry

Professional & Technical Services

What the Filing Says About Revance Therapeutics, Inc. 401(k) P/S Plan

Revance Therapeutics, Inc. 401(k) P/S Plan is a 401(k) retirement plan sponsored by Revance Therapeutics, Inc., headquartered in Tennessee. As of the 2022 Form 5500 filing, the plan reports $41M in total end-of-year assets and covers 493 participants across the Professional & Technical Services industry. The sponsor's EIN on file with the U.S. Department of Labor is 770551645, and the plan has been effective since 2004-01-01. Its filing status is currently FILING RECEIVED.

Year over year, total assets moved from $43M at the beginning of 2022 to $41M at year-end — a decline of 5.6%. Net assets (after liabilities) closed the year at $41M, with reported net income of $-2,448,574 driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.

Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows — a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.

Financial Summary (2023)

Total Assets (Beginning of Year)	$43M
Total Assets (End of Year)	$41M
Net Assets (End of Year)	$41M
Net Income	$-2,448,574
Plan Type	401(k)
Employer EIN	770551645
Plan Effective Date	2004-01-01
Filing Status	FILING RECEIVED

Sponsor Plan History (Revance Therapeutics, Inc.)

Year	Plans	Participants	Total Assets
2022	1	493	$41M
2023	1	532	$60M
2024	1	594	$69M

Nearby 401(k) Plans in Tennessee

Peer 401(k) plans — same state, same plan type — ranked by total assets.

Fedex Corporation Retirement Savings Plan $23.9B · 127,010
Hca 401(k) Plan $21.5B · 291,649
Federal Express Corporation Pilots Retirement Savings Plan $4.7B · 5,728
International Paper Company Salaried Savings Plan $4.6B · 12,153
Chs/Community Health Systems, Inc. Retirement Savings Plan $4.5B · 62,487

Compare Revance Therapeutics, Inc. 401(k) P/S Pl… side-by-side with 3 peers →

Related Data

Guides

Frequently Asked Questions

How much money is in the Revance Therapeutics, Inc. 401(k) P/S Plan? ▼

As of the 2022 Form 5500 filing, Revance Therapeutics, Inc. 401(k) P/S Plan holds $41M in total assets with 493 participants. It is sponsored by Revance Therapeutics, Inc..

What type of plan is Revance Therapeutics, Inc. 401(k) P/S Plan? ▼

Revance Therapeutics, Inc. 401(k) P/S Plan is a 401(k) plan. It has been effective since 2004-01-01. The plan is filed with the U.S. Department of Labor under EIN 770551645.

Who sponsors the Revance Therapeutics, Inc. 401(k) P/S Plan? ▼

Revance Therapeutics, Inc. 401(k) P/S Plan is sponsored by Revance Therapeutics, Inc., located in Tennessee. The sponsor's EIN is 770551645 and the plan operates in the Professional & Technical Services industry.

How did Revance Therapeutics, Inc. 401(k) P/S Plan perform in 2022? ▼

Revance Therapeutics, Inc. 401(k) P/S Plan declined by 5.6% during 2022, moving from $43M to $41M in total assets. Net income was $-2,448,574.

Where can I find official filings for Revance Therapeutics, Inc. 401(k) P/S Plan? ▼

Official Form 5500 filings for Revance Therapeutics, Inc. 401(k) P/S Plan are available through the U.S. Department of Labor's EFAST2 system. Search by EIN 770551645 or plan name at efast.dol.gov.

How does Revance Therapeutics, Inc. 401(k) P/S Plan compare to other plans? ▼

You can compare Revance Therapeutics, Inc. 401(k) P/S Plan against other 401(k) plans on the plan type page, or view plans in Tennessee on the state page. PlainRetire tracks the 5,000 largest retirement plans in the U.S. by total assets.